Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.
about
Lung cancer signatures in plasma based on proteome profiling of mouse tumor modelsDifferential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cellsG Protein-Coupled Receptor Signaling in Stem Cells and CancerADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.A functional role for ADAM10 in human immunodeficiency virus type-1 replicationADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.Detection of a secreted metalloprotease within the nuclei of liver cellsProteases and sFlt-1 release in the human placentaExpression of a-disintegrin and metalloproteinase 10 correlates with grade of malignancy in human glioma.Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patientsTestosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.Versican processing by a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats proteinases-5 and -15 facilitates myoblast fusion.Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.Putative molecular signatures for the imaging of prostate cancer.Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer.Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array.Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression.Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms.Aberrant expression of disintegrin-metalloprotease proteins in the formation and progression of uterine cervical cancer.CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropismNuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer.Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer.Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain.Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas.Tumor necrosis factor-α-induced a disintegrin and metalloprotease 10 increases apoptosis resistance in prostate cancer cells.ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretaseBPH gene expression profile associated to prostate gland volumeAn atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.ADAM-10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis.Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates.Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.Distinct Expression and Function of FcεRII in Human B Cells and Monocytes.ADAM10 mediates N-cadherin ectodomain shedding during retinal ganglion cell differentiation in primary cultured retinal cells from the developing chick retina.
P2860
Q24628852-6A249CE1-B61A-4EB7-A049-C85AC991EB11Q24648981-74A30DA5-2A37-4921-8288-A5A6F571EF30Q26853233-048E2609-1965-41EC-9A51-6DC717EF3B0CQ33346972-AA6D47A7-CCD9-41B4-9659-C53D093A2CC9Q33898509-8F429318-0EE4-4B05-A00C-A65C7009C70CQ34334333-3650E1AF-4CC8-4B5A-912D-FA4F4137EB38Q35083378-D7934318-EBFD-4F4C-8952-B29B4E88AC5AQ35671379-29B3B0B4-9DDA-49A2-AC37-5CAC9B454B0EQ35742031-DD4C8895-AADE-41A3-B741-77C3DC912A3FQ36102628-54DFB571-DA1D-42F4-8C80-72004F9AE097Q36271731-1807D164-395C-4412-9205-5F7908919446Q36543792-C2DF66A1-5A9C-4C37-808D-093E8F777133Q37233980-CDE668BD-BA65-422C-AF13-11A15EC4DD5AQ37656266-6BD8F6CC-88BF-45A4-8CD7-5ADC5F54BAB1Q37701529-2533DBCF-362F-472F-828A-4BCDC1FCD80EQ38679713-E36A254C-988B-4217-BCA3-3F3D2C16AAD8Q38923909-5799B1C3-0D73-4185-B9BF-272F1E38CE82Q38963327-837A9B1B-9AD7-49B3-BEFB-91120E7142F9Q39214249-ECACCC76-3B4B-4C07-8A0F-5DC5A5138853Q39536282-49EFA2A0-E9E3-4693-B3BF-7B0CC30E59A9Q40002581-A6A613D2-948D-4927-8666-DD4D7E516E29Q40087975-218B94B1-95AD-4637-884C-FCF4CBB19E55Q40329185-CAF09B7E-2C1C-42D0-8F1A-5522FE1FC962Q40554114-BA356ACC-DE95-4246-A696-5A3C5A4F6D77Q40601806-BCA717AA-1B1E-4CD7-8539-76CB83E71CF3Q41487801-29C34EAE-516E-4F30-B88C-8FC41D0C6762Q41890825-C6FF1D14-38B7-4C00-B172-89A64502D7A4Q42059040-2327E83E-3F2A-4E7E-975D-2B5ADC7E3C3AQ42103664-67F0FB86-2391-42FB-BD86-4B08F04F7A4AQ45869295-20821905-98DE-46FD-8DD3-DD296A118DCEQ46123753-0049252B-E40D-4304-B45C-B3B139E530F8Q47132181-C1757AA2-792A-402C-98A5-1B9607EC27ABQ47936787-556A4BA6-EEF2-4EA1-9BE6-E1C4948881C6Q47954707-AEA894E0-BD8D-4723-9855-C13A87D281E5Q53354614-5EC935A2-5ACD-43C6-91BE-CF0A199EC8E0
P2860
Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expression of the disintegrin ...... state cancer cell model LNCaP.
@en
type
label
Expression of the disintegrin ...... state cancer cell model LNCaP.
@en
prefLabel
Expression of the disintegrin ...... state cancer cell model LNCaP.
@en
P50
P1476
Expression of the disintegrin ...... ostate cancer cell model LNCaP
@en
P2093
Dimitri M Odorico
Pascal Akl
P304
P356
10.1158/1078-0432.CCR-0846-3
P407
P433
P577
2004-01-01T00:00:00Z